“Update on stock $BIO | Analysts' outlook for the next 12 months:

The current price is $285, and the recent performance (‘+25% in 3 months’) reflects a notable recovery.

The average forecasts range from $324 to $334, indicating a potential growth of about +15-17% over the year.

However, there are optimistic projections reaching $409 (+43%), and more conservative ones reaching $265 (–7%).

In your opinion, should we continue to follow the positive shift of the stock towards the $330-340 range, or wait for an initial correction towards $265? Share your thoughts with me!”